Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience

Background. Oncocytoma is one of the most common benign kidney tumors, accounting for 3–7% of all solid renal masses. Diagnosing oncocytomas using renal biopsy remains a controversy in the uro-pathologic community. With the increasing use of biopsies for assessment of renal lesions, reaching this pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen Mayer, Yasmin Abu-Ghanem, Zohar A. Dotan, Iris Barshack, Eddie Fridman
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2022/1589040
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562349390692352
author Chen Mayer
Yasmin Abu-Ghanem
Zohar A. Dotan
Iris Barshack
Eddie Fridman
author_facet Chen Mayer
Yasmin Abu-Ghanem
Zohar A. Dotan
Iris Barshack
Eddie Fridman
author_sort Chen Mayer
collection DOAJ
description Background. Oncocytoma is one of the most common benign kidney tumors, accounting for 3–7% of all solid renal masses. Diagnosing oncocytomas using renal biopsy remains a controversy in the uro-pathologic community. With the increasing use of biopsies for assessment of renal lesions, reaching this pathologically benign diagnosis may prevent further surgical measures and have significant clinical benefit. Objective. To demonstrate our center’s results using renal biopsy to diagnose oncocytomas and to suggest that this diagnosis can be made with high success rates. Design, Setting, and Participants. From our center’s database, we retrospectively identified and retrieved all cases of oncocytoma diagnosed between the years 2011 and 2020 by renal biopsy. Medical records of those patients were then reviewed to view follow-up meetings and imaging of the lesions biopsied. Outcome Measurements and Statistical Analysis. In 21 biopsies performed on 19 patients, diagnosis was supported by subsequent follow-up averaging at 3.44 years per patient. Results and Limitations. The lesions exhibited benign behavior during follow-up after biopsy, consistent with the diagnosis of oncocytoma. Conclusions. Our study demonstrates that with good patient selection and proficient cooperation between urologists, radiologists and dedicated uro-pathologists, correctly diagnosing oncocytomas using RCB is a viable task. Patient Summary. Oncocytomas are benign lesions of the kidney. In our study, we reviewed all cases of oncocytomas pathologically diagnosed using renal biopsy from our center’s database. We found that in subsequent follow-up later to biopsy, the lesions displayed benign behavior consistent with oncocytoma. The use of percutaneous biopsies to reach this diagnosis could save patients more extensive surgeries.
format Article
id doaj-art-278be9df5f384d2db55d11aaf025769c
institution Kabale University
issn 1687-6377
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Advances in Urology
spelling doaj-art-278be9df5f384d2db55d11aaf025769c2025-02-03T01:22:52ZengWileyAdvances in Urology1687-63772022-01-01202210.1155/2022/1589040Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center ExperienceChen Mayer0Yasmin Abu-Ghanem1Zohar A. Dotan2Iris Barshack3Eddie Fridman4Institute of PathologyUrology DepartmentUrology DepartmentInstitute of PathologyInstitute of PathologyBackground. Oncocytoma is one of the most common benign kidney tumors, accounting for 3–7% of all solid renal masses. Diagnosing oncocytomas using renal biopsy remains a controversy in the uro-pathologic community. With the increasing use of biopsies for assessment of renal lesions, reaching this pathologically benign diagnosis may prevent further surgical measures and have significant clinical benefit. Objective. To demonstrate our center’s results using renal biopsy to diagnose oncocytomas and to suggest that this diagnosis can be made with high success rates. Design, Setting, and Participants. From our center’s database, we retrospectively identified and retrieved all cases of oncocytoma diagnosed between the years 2011 and 2020 by renal biopsy. Medical records of those patients were then reviewed to view follow-up meetings and imaging of the lesions biopsied. Outcome Measurements and Statistical Analysis. In 21 biopsies performed on 19 patients, diagnosis was supported by subsequent follow-up averaging at 3.44 years per patient. Results and Limitations. The lesions exhibited benign behavior during follow-up after biopsy, consistent with the diagnosis of oncocytoma. Conclusions. Our study demonstrates that with good patient selection and proficient cooperation between urologists, radiologists and dedicated uro-pathologists, correctly diagnosing oncocytomas using RCB is a viable task. Patient Summary. Oncocytomas are benign lesions of the kidney. In our study, we reviewed all cases of oncocytomas pathologically diagnosed using renal biopsy from our center’s database. We found that in subsequent follow-up later to biopsy, the lesions displayed benign behavior consistent with oncocytoma. The use of percutaneous biopsies to reach this diagnosis could save patients more extensive surgeries.http://dx.doi.org/10.1155/2022/1589040
spellingShingle Chen Mayer
Yasmin Abu-Ghanem
Zohar A. Dotan
Iris Barshack
Eddie Fridman
Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience
Advances in Urology
title Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience
title_full Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience
title_fullStr Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience
title_full_unstemmed Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience
title_short Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience
title_sort diagnosing oncocytoma by core needle biopsy a single center experience
url http://dx.doi.org/10.1155/2022/1589040
work_keys_str_mv AT chenmayer diagnosingoncocytomabycoreneedlebiopsyasinglecenterexperience
AT yasminabughanem diagnosingoncocytomabycoreneedlebiopsyasinglecenterexperience
AT zoharadotan diagnosingoncocytomabycoreneedlebiopsyasinglecenterexperience
AT irisbarshack diagnosingoncocytomabycoreneedlebiopsyasinglecenterexperience
AT eddiefridman diagnosingoncocytomabycoreneedlebiopsyasinglecenterexperience